Stock EIGR EIGER BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Delayed OTC Markets
Other stock markets
 10:23:01 2024-05-20 EDT 		5-day change 1st Jan Change
2.27 USD -11.05% Intraday chart for Eiger BioPharmaceuticals, Inc. +0.89% -66.30%
05-08 Sentynl Therapeutics, Inc. acquired Global rights to Zokinvy Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $45.2 million. CI
05-06 Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug MT
d58c9cc16a366e27c75f.009vWSMur-tHO4eo0xPelsiBdkJVVeliCynoIwKia00.5hcqIWgagt42Tb_Zg3aw-7jEMA8zENA1chysDnXkGjqGBQMPGniWiiFc6A~85dc68d57d9b18bd5e2d0cbcad2e58a8
  1. Stock Market
  2. Equities
  3. EIGR Stock
  4. Charts Eiger BioPharmaceuticals, Inc.
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW